Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis-MedSci.cn

Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis

Chick, RC; Faries, MB; Hale, DF; Bohan, PMK; Hickerson, A; Vreeland, TJ; Myers, JW; Cindass, JL; Brown, TA; Hyngstrom, JR; Jakub, JW; Sussman, JJ; Berger, AC; Shaheen, MF; Clifton, GT; Wagner, T; Peoples, GE

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (5):

科室
- - 订阅+
  - 更多科室
工具
服务